...

N163-166 mod6

Molecular wt
488.5
Compound class
VDAC1-derived tetrapeptide with a D-valine
Batch
KC-N63-01
Made
2026-01-20
Reports
2 on file
Everything shipping from this page today came off this batch. The code is printed on your label, and one certificate covers the whole batch.

N163-166 mod6

250mcg Per Dry-Fill Enteric Capsule

60ct

15mg

N163-166 (mod6) is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms and Conditions prior to ordering.

SSL secure checkout

256-bit encryption

3rd party verified

HPLC and mass spectrometry

Description

N163-166 mod6 (VDAC1-Derived Peptide) Research Standard

N163-166 mod6 is a specialized, synthetic VDAC1-derived tetrapeptide designed to modulate mitochondrial cholesterol transport. By targeting the interaction between the voltage-dependent anion channel 1 (VDAC1) and the steroidogenic transduceosome complex, this peptide serves as a research tool for studying the rate-limiting step of steroidogenesis. Specifically, N163-166 mod6 is utilized to investigate the selective enhancement of testosterone biosynthesis through increased mitochondrial cholesterol availability, while maintaining neutral activity regarding corticosterone production, offering a precise model for researching androgen-specific signaling.

Technical Specifications

Property Specification
Product Name N163-166 mod6
Origin VDAC1 (Voltage-Dependent Anion Channel 1)
Sequence Modification Arg-D-Val-Ser-Gln (R-D-V-S-Q)
Molecular Weight ~488.2 g/mol
Chemical Class VDAC1-derived bioactive tetrapeptide
Physical Appearance Lyophilized powder
Assay Purity Refer to the batch-specific Certificate of Analysis (COA) supplied for the lot received

Mechanism of Action (Pharmacological Context)

N163-166 mod6 functions by modulating the mitochondrial transduceosome, a multiprotein complex responsible for the translocation of cholesterol into the mitochondria—the rate-limiting step in steroidogenesis.

  • Cholesterol Transport: The peptide acts by interacting with VDAC1, which functions as a gatekeeper in the outer mitochondrial membrane. By disrupting inhibitory interactions (such as the 14-3-3epsilon binding to VDAC1), the peptide facilitates the recruitment of the Steroidogenic Acute Regulatory protein (StAR) and cholesterol import.

  • Testosterone Specificity: Research indicates that this mechanism specifically promotes androgen biosynthesis within Leydig cells. Notably, data suggests this enhancement occurs without stimulating a corresponding increase in corticosterone production, differentiating it from generalized steroidogenic stimulants.

  • D-Valine Modification: The inclusion of D-Valine in this specific “mod6” variant serves to increase proteolytic stability in in vitro and in vivo research models, preventing rapid degradation and allowing for more controlled kinetic analysis.

Research Applications

N163-166 mod6 is a pivotal tool for exploring mitochondrial dynamics and androgenic signaling.

Primary fields of in vitro and in vivo laboratory investigation include:

  • Steroidogenic Pathway Mapping: Studying the protein-protein interactions (PPIs) between VDAC1, TSPO, and StAR.

  • Mitochondrial Cholesterol Flux: Measuring the rate of cholesterol entry into the mitochondrial matrix under stimulated and basal conditions.

  • Androgen-Specific Signaling: Investigating why this peptide scaffold specifically upregulates testosterone biosynthesis while remaining selective relative to other steroid pathways (e.g., corticosterone).

  • Proteolytic Stability Research: Utilizing the D-Valine-modified tetrapeptide to benchmark how stereochemical variations improve the half-life of short-chain bioactive peptides.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

References

  • Martinez-Arguelles DJ, et al. (2023) Oral administration of VDAC1-derived small molecule peptides increases circulating testosterone levels in male rats. Frontiers in Endocrinology. 13:1003017. doi:10.3389/fendo.2022.1003017.

  • Aghazadeh Y, et al. (2014) Peptide Targeting of Mitochondria Elicits Testosterone Formation. Molecular Therapy. 22(8):1511-1520.

Related Research Compounds

Research Use Disclaimer

Research Use Only Disclaimer: This product is developed and distributed strictly as a Research Use Only (RUO) laboratory reference chemical intended exclusively for non-clinical analytical and scientific investigation. It is not an FDA-approved drug, medical treatment, dietary supplement, or food ingredient, and is strictly prohibited for human or animal consumption. Kimera Chems supplies this research material solely to qualified institutions and professional investigators for authorized laboratory research.

Compound Class VDAC1-derived tetrapeptide with a D-valine
Molecular Formula C₁₉H₃₆N₈O₇
Molecular Weight 488.5
Capsule Concentration 250mcg (Enteric)

Certificates of Analysis

Currently shipping from batch KC-N63-01.